BioSpace News Archive

Theravance Biopharma, Inc. and Mylan N.V. announced the presentation of data from its pivotal Phase 3 efficacy studies and a 52-week safety study at the 2019 American Thoracic Society International Conference in Dallas, Texas.

BRG today announces the hire of John Brock as a Managing Director and healthcare industry leader in the firm’s Transaction Advisory practice

Individuals and Organizations Honored for Positive Global Impact of Radiology Services at American College of Radiology Annual Meeting

Teen drivers diagnosed with attention-deficit hyperactivity disorder (ADHD) are significantly more likely to crash, be issued traffic and moving violations, and engage in risky driving behaviors than their peers without ADHD, according to a Children’s Hospital of Philadelphia (CHOP) study published today in the journal Pediatrics.

The kidneys of patients living with systemic lupus erythematosus (SLE) are often under assault, and not all those living with the disease will respond to standard treatment.

HeartCare Imaging (HCI) has been selected by Modern Healthcare as one of the 2019 Best Places to Work in Healthcare

Emergency Nurses Association’s largest Day on the Hill event takes place this week

Ocular Therapeutix™, Inc. announced topline results from the first pivotal Phase 3 clinical trial of OTX-TP, an intracanalicular insert that delivers a preservative-free formulation of the drug travoprost for the reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.

Repro Med Systems, Inc. dba RMS Medical Products announced that Executive Chairman Dan Goldberger is scheduled to present at the 9th Annual LD Micro Invitational on June 5, 2019.

Thermo Fisher Scientific Inc., the world leader in serving science, announced that it is investing more than $50 million in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioprocess container systems.